Clincosm LogoSign in Get a demo

acute myeloid leukemia, adult

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia, Adult
    • Freiburg, CA, Germany
      Medical Center- University of Freiburg
    Aug 4, 2023

    Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • cladribine + homoharringtonine + cytarabine
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Zhejiang University School of Med
    Jun 13, 2023

    Acute Myeloid Leukemia, Adult, Cardiotoxicity, Endothelial Dysfunction Trial in Samara (History taking, Anthropometry, Complete

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • History taking
    • +14 more
    • Samara, Samara Region, Russian Federation
      Clinics of the Samara Medical University
    Jan 26, 2023

    Acute Myeloid Leukemia, Adult, MDS Trial in Marseille, Paris, Pierre-Bénite (ABD-3001)

    Active, not recruiting
    • Acute Myeloid Leukemia, Adult
    • Myelodysplastic Syndromes
    • Marseille, France
    • +2 more
    Jan 19, 2023

    Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Fludarabine and Busulfan
    • Fludarabine and Melphalan
    • Wuhan, Hubei, China
      Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
    Jan 5, 2023

    Acute Myeloid Leukemia, Adult Trial in Houston (ADI-PEG 20)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • ADI-PEG 20
    • Houston, Texas
      MD Anderson Cancer Center
    Sep 29, 2022

    Acute Myeloid Leukemia, Adult Trial in Hanzhou (Clifutinib Besylate)

    Not yet recruiting
    • Acute Myeloid Leukemia, Adult
    • Clifutinib Besylate
    • Hanzhou, China
      the First Affiliated Hospital,College of Medicine,Zhejiang Unive
    May 4, 2022

    Acute Myeloid Leukemia, Adult Trial in Germany (Midostaurin)

    Terminated
    • Acute Myeloid Leukemia, Adult
    • Chemnitz, Germany
    • +3 more
    Jan 20, 2022

    Acute Myeloid Leukemia, Adult Trial in La Plata, Caba (Evaluation of first line treatment with intensive treatment outcome in

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • Evaluation of first line treatment with intensive treatment outcome in adult patients with AML.
    • La Plata, Buenos Aires, Argentina
    • +1 more
    Nov 9, 2021

    Acute Myeloid Leukemia, Adult Trial in Suzhou (venetoclax combined with decitabine)

    Unknown status
    • Acute Myeloid Leukemia, Adult
    • venetoclax combined with decitabine
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Nov 8, 2021

    Acute Myeloid Leukemia, Adult, AML, AML, Adult Trial in La Jolla (Fludarabine, Vyxeos)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • La Jolla, California
      UCSD Moores Cancer Center
    Mar 30, 2021

    Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Trieste, Italy
      SC Ematologia Ospedale Maggiore
    Sep 14, 2020

    Acute Myeloid Leukemia, Adult Trial in Mexico city, Mexico City (Experimental group, Control group)

    Unknown status
    • Acute Myeloid Leukemia, Adult
    • Experimental group
    • Control group
    • Mexico city, Mexico
    • +1 more
    Sep 2, 2020

    Acute Myeloid Leukemia, Adult Trial in Roma (Up-front allogeneic hematopoietic stem cell transplantation (HSCT))

    Unknown status
    • Acute Myeloid Leukemia, Adult
    • Up-front allogeneic hematopoietic stem cell transplantation (HSCT)
    • Roma, RM, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Apr 8, 2019

    Acute Myeloid Leukemia, Adult Trial (Decitabine, Cytarabine)

    Unknown status
    • Acute Myeloid Leukemia, Adult
    • (no location specified)
    Dec 3, 2016